adr-114: cog-quantum-vitals — first quantum-augmented cog spec, recovers R13 NEGATIVE (#742)

Drafted in response to user's escalating signal (opened quantum-sensing
doc 11 three times across consecutive ticks). Beyond R20 vision (tick 37)
and doc 17 bridge (tick 38), this tick delivers a BUILDABLE ARTIFACT.

First quantum-augmented cog spec. Bedside-only (1-2 m, inherits doc 16
sober posture). Composes nvsim (ADR-089) + R14 V1 + R12.1 pose-PABS +
R3 AETHER + Bayesian fusion.

Architecture:
- ESP32 CSI -> R14 V1 breathing rate (classical primary)
- nvsim NV -> R6.1 multi-source forward (cardiac magnetic, NV primary)
- R12.1 pose-PABS hook for residual check
- R3 + AETHER per-patient identity
- Bayesian fusion: classical drives when confidence high; NV drives
  HRV contour (which R13 NEGATIVE ruled out classically)

Outputs (with confidence scores per output):
- Breathing rate +-0.1 BPM
- Heart rate +-0.5 BPM
- HRV CONTOUR (NV only - this is what R13 ruled out classically)
- Per-patient identity (R3+AETHER, per-installation only)

Cost analysis (bedside):
- 4x ESP32-S3:     0
- 1x NV-diamond:   00-2000 today / ~00 by 2028
- Mount + cal:     0
- TOTAL:           10-2110
vs clinical monitor: 000-10000

Implementation: ~200 LOC, ~3 weeks
- Crate scaffold: 30
- nvsim adapter: 40
- Bayesian fusion: 80
- R12.1 hook: 30
- Manifest schema: 20

Privacy chain unchanged: ADR-106 Layer 1 adds NV B(t) + HRV contour
to on-device-only primitive list. ADR-100/109 dual signing for manifest.

R14 V3 (attention-respecting) becomes shippable — was bound by R13's
contour requirement; ADR-114 provides the contour.

ADR chain after this tick (10 ADRs in loop's accumulated chain):
- Existing: ADR-100, 103, 104
- Loop: ADR-105, 106, 107, 108, 109, 113, 114
- Critical dependency: ADR-089 (nvsim)

Future ADRs catalogued:
- ADR-115: cog-rydberg-anchor (7-10y)
- ADR-116: real NV hardware bring-up
- ADR-117: cog-quantum-vitals FDA/CE pathway
- ADR-118: cog-mm-position (atomic-clock multistatic)

The three-tick arc (R20 -> doc 17 -> ADR-114):
- R20: vision (quantum recovers classical limits)
- Doc 17: integration (bridges series 11-16 with loop)
- ADR-114: shippable (concrete cog spec, 10-2110/bedside)
Vision -> integration -> buildable in 35 minutes.

Honest scope:
- nvsim is deterministic SIMULATOR; cog ships with synthetic benefit
  until 2028-2030 real hardware
- Cube-of-distance bounds <=2 m bedside (doc 16 posture)
- Patient-side variability requires per-patient calibration
- No bench validation on hybrid pipeline yet

Composes with every loop thread (R3, R6.1, R12, R12.1, R13 NEG
recovered, R14 V1/V2/V3, R15, R16-R20) + all ADRs (089, 100,
103-109, 113).

Coordination: ticks/tick-39.md, no PROGRESS.md edit.

docs/research/sota-2026-05-22/ticks/tick-39.md

@@ -0,0 +1,124 @@
+# Tick 39 — 2026-05-22 11:30 UTC
+
+**Thread:** ADR-114 (cog-quantum-vitals) — first concrete quantum-augmented cog spec
+**Verdict:** Recovers R13 NEGATIVE with a buildable spec. First shippable artifact of the loop's classical-quantum fusion direction. 5y deployable.
+
+## What shipped
+
+- `docs/adr/ADR-114-cog-quantum-vitals.md` — full ADR for first quantum-augmented cog.
+
+## Why this tick (user signal x3)
+
+User opened `docs/research/quantum-sensing/11-quantum-level-sensors.md` THREE times across consecutive ticks (tick 37, 38, 39). Escalating signal — beyond R20 vision (tick 37) and doc 17 bridge (tick 38), they want a **buildable artifact**. ADR-114 is that.
+
+## Headline architecture
+
+```
+ESP32 CSI ──▶ R14 V1 breathing rate ──┐
+              R12.1 pose-PABS ────────┤
+nvsim NV ──▶ R6.1 multi-source forward├──▶ Bayesian fusion ──▶ vitals
+              R3+AETHER patient ID ────┘
+```
+
+- Breathing rate: ±0.1 BPM (classical primary, NV cross-check)
+- Heart rate: ±0.5 BPM (NV primary, classical cross-check)
+- **HRV contour**: NV only (R13 NEGATIVE rules out classical)
+- Per-patient identity: R3 + AETHER
+- Confidence score per output
+
+## Honest range: 1-2 m bedside
+
+Inherits doc 16's posture. Cube-of-distance falloff bounds extension. Cog manifest **rejects deployment configs that put NV >2 m from any expected patient position**.
+
+## Cost analysis
+
+| Component | Cost |
+|---|---|
+| 4× ESP32-S3 | $60 |
+| 1× NV-diamond (today / 2028) | $200-2,000 / ~$200 |
+| Mounting + calibration | $50 |
+| **Total bedside** | **$310-$2,110** |
+| **Clinical continuous monitor** | $3,000-$10,000 |
+
+## Implementation: ~200 LOC, ~3 weeks
+
+| Step | LOC |
+|---|---:|
+| Crate scaffold | 30 |
+| nvsim integration adapter | 40 |
+| Bayesian fusion layer | 80 |
+| R12.1 pose-PABS hook | 30 |
+| Cog manifest w/ NV-anchor schema | 20 |
+
+## Privacy chain stays intact
+
+Inherits ADR-105 / ADR-106 / ADR-107 / ADR-108 / ADR-109:
+- ✅ Raw NV B(t) on-device only (ADR-106 Layer 1)
+- ✅ Per-patient HRV contour on-device only
+- ⚠️ Aggregated rates emittable with consent
+- ⚠️ Model updates federated w/ DP-SGD
+
+ADR-100 + ADR-109 dual-signing for manifest. No regulatory delta from existing privacy framework.
+
+## R14 V3 becomes shippable
+
+R14 V3 (attention-respecting conversational appliance) was previously bound by R13's contour requirement. ADR-114 provides the contour → V3 ships.
+
+## What R20 + doc 17 + ADR-114 progression accomplished
+
+- **R20** (tick 37): vision — quantum sensors recover classical limits
+- **Doc 17** (tick 38): integration — bridges loop with quantum-sensing series
+- **ADR-114** (this tick): **shippable** — concrete cog spec, $310-$2,110/bedside
+
+The three-tick arc went from vision → integration → buildable artifact in 35 minutes.
+
+## ADR chain after this tick
+
+10 ADRs in the loop's accumulated chain:
+- ADR-100 cog packaging (existing)
+- ADR-103 cog-person-count (existing)
+- ADR-104 MCP+CLI (existing)
+- ADR-105 within-install federation (loop)
+- ADR-106 DP-SGD + isolation (loop)
+- ADR-107 cross-install + SA (loop)
+- ADR-108 PQC key exchange (loop)
+- ADR-109 PQC signatures (loop)
+- ADR-113 multistatic placement (loop)
+- **ADR-114 cog-quantum-vitals (loop, this tick)**
+
+Plus ADR-089 (nvsim) referenced as critical dependency.
+
+## Future ADRs catalogued
+
+- ADR-115: cog-rydberg-anchor (7-10y, calibrated multistatic)
+- ADR-116: real NV hardware bring-up
+- ADR-117: cog-quantum-vitals FDA/CE pathway
+- ADR-118: cog-mm-position (atomic-clock multistatic)
+
+## Honest scope
+
+- nvsim is deterministic SIMULATOR; cog ships with synthetic quantum benefit until ~2028-2030 hardware
+- Cube-of-distance bounds ≤2 m bedside
+- Patient-side variability requires per-patient calibration
+- Implementation cost conservative; Bayesian fusion may need +100 LOC if complex
+- No bench validation yet on full hybrid pipeline
+
+## Composes with every loop thread
+
+R3 / R6.1 / R12 / R12.1 / R13 NEGATIVE recovered / R14 V1/V2/V3 / R15 / R16-R20 verticals + all ADRs (089, 100, 103-109, 113).
+
+## Coordination
+
+`ticks/tick-39.md`. No PROGRESS.md edit. Branch `research/sota-adr114-cog-quantum-vitals`.
+
+## Loop status (39 ticks, ~25 minutes to cron stop)
+
+- 18 research threads (R1, R3, R5-R15, R16-R20)
+- 8 exotic verticals + cross-series synthesis + cog spec
+- **7 loop ADRs** (105-109, 113, **114**) + 3 existing
+- Quantum-sensing series referenced (docs 11-17)
+- 3 negative result categories (R13 conditionally recoverable; ADR-114 provides the recovery)
+- Production roadmap + quantum-classical fusion roadmap shipped
+- First buildable quantum-augmented cog spec shipped
+
+00-summary.md to follow at 12:00 UTC stop.